Analysis of the decisions of foreign regulatory authorities
Analysis of recommendations of foreign regulatory authorities on the restriction of circulation of medicines and/or the need for changes in the instructions for their medical use due to changes in the safety profile, conducted by experts of the Scientific Centre for Expert Evaluation of...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2019-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Analysis of recommendations of foreign regulatory authorities on the restriction of circulation of medicines and/or the need for changes in the instructions for their medical use due to changes in the safety profile, conducted by experts of the Scientific Centre for Expert Evaluation of Medicinal Products revealed 25 administrative decisions of foreign regulatory authorities. These decisions contained information on the following medicines registered in Russia: apixaban, granulocyte-macrophage colony stimulating factor, hydroxyethyl starch, dabigatran, eltrombopag, epoetin alfa, atypical antipsychotic drugs, benzocaine, varenicline, carbamazepine, lamotrigine, suvorexant, topiramate, aztreonam, azithromycin, isoniazid, caspofungin, miconazole, meropenem, atazanavir, dolutegravir, lamivudine, efavirenz. |
|---|---|
| Item Description: | 2312-7821 2619-1164 10.30895/2312-7821-2019-7-2-99-104 |